Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Smoking Cessation in African American Light Smokers
NCT00666978Phase 4Completed
- Start
- Dec 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupropion in Tobacco Use Disorder (TUD) (2 arms). Primary endpoint: Salivary Cotinine-verified Smoking Abstinence at 6 months. Started Dec 2007; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00666978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666978.